GARCEAU ROGER 4
4 · Protara Therapeutics, Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
GARCEAU ROGER
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-12+24,000→ 24,000 totalExercise: $3.26From: 2026-06-12Exp: 2035-06-11→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.